AAFP Says CMS Should Negotiate Drug Prices AAFP Congress wraps up with a series of actions targeting cost and access Sep 21, 2016
AAFP Elections: Munger Wins 3-Way Race for President-Elect John Meigs Jr., MD installed as AAFP president Sep 21, 2016
AAFP Blinks on Single-Payer and DTC Drug Ads AAFP delegates stopped short of making new policy on single-payer and a ban on DTC ads Sep 20, 2016
AAFP: MOC Debate Roils Delegates Ditching 'high stakes exam' could reduce fear factor, but ... Sep 20, 2016
HFSA: Treat to NT-proBNP Target Flops in Trial Outcomes no better with treatment aimed at 30% reduction Sep 20, 2016
AAFP Urged to Take Action to Prevent Burnout Delegates demand more than seminars, articles, and phone numbers Sep 19, 2016
HFSA: Did LAP Monitoring Cut HF Rehospitalizations? LAPTOP-HF investigators tried to make sense of terminated study Sep 19, 2016
SGLT2/GLP-1 Combo Better Than Monotherapy After Metformin Going straight to combo improves glycemic control, weight loss Sep 19, 2016
AAFP Exec Declares Healthcare 'Fundamental Human Right' Tearful entreaty mixed with scolds Sep 19, 2016
Women with T2D Face Higher Fracture Risk Chances for osteoporotic breaks climb after a decade with type 2 diabetes Sep 18, 2016
Remyelinating Drug Flops in MS Large placebo response, 'inverted U-shaped' dose-response in phase II trial Sep 18, 2016
Registry Data: Lemtrada More Effective than Competing MS Tx Better than fingolimod or interferon; comparable to natalizumab Sep 17, 2016
Low Vitamin D Linked with All-Cause Death There was a significant interaction by race, with greater risks for whites Sep 17, 2016
New Ampyra Trial Bolsters MS Efficacy Claims Walking ability, as reported by patients, significantly improved Sep 17, 2016
Fluoxetine Flops as Progressive MS Therapy Trial may have been underpowered to detect a benefit Sep 17, 2016
Rituximab Bests MS Drugs in Swedish Registry Rituximab offered drug survival advantage over fingolimod, natalizumab Sep 16, 2016
Longer-Term Home Use Safe for Artificial Pancreas System 3-month study might pave way to FDA clearance Sep 16, 2016
Another GLP-1 Wins on Cardio Prevention Novel semaglutide reduced major CV event risk in large outcomes trial Sep 16, 2016
The Lancet Versus BMJ: A Dispatch From the Statin Wars The editors of the two top U.K. medical journals are in a bitter fight Sep 15, 2016
Januvia/Metformin Combo Gets Boost from Novel SGLT2 T2D patients uncontrolled on duo do better when adding ertugliflozin Sep 15, 2016
CGM for T1D Reduces Hypoglycemia Less time outside range for reduced hypo awareness patients in trial Sep 15, 2016
CML Patients Still Benefit from Transplant Also at SOHO: Ponatinib proves mettle in pretreated CML Sep 13, 2016
Switching GLP-1 For DPP-4 Improves Net T2D Outcomes Victoza bests Januvia for combo therapy on A1c, weight, hypoglycemia composite Sep 13, 2016
How Sweet: Sugar Industry Made Fat the Villain Harvard researchers received sugar industry money to write a NEJMreview Sep 12, 2016
Survey Finds Many People Lack NSAID Knowledge Patients fail to ID these drugs or associated risks Sep 12, 2016
Nursing Student Diary: First Days 'Proud, excited, nervous, confident, all at the same time' Sep 12, 2016
JACC Retracts AF Ablation Trial Lead author Andrea Natale claims undue industry influence Sep 11, 2016
Patients Needing High-Dose Opioids May Have Genetic Defects Defective activity levels require extra meds for pain control Sep 11, 2016
Lowering the Bar: Adult ADHD, a Risky Diagnosis? As adult ADHD diagnoses increase, so do stimulant overdoses Sep 10, 2016
Lowering the Bar: Patient or Addict? For some an ADHD diagnosis is a ticket to ride the stimulant express Sep 10, 2016
Opioid Abuse: The Economic Burden on Payers Study finds excess costs ramp up before the initial diagnosis Sep 10, 2016
EndoBreak: Lexicon Rides a Wave of Good News; Obesity Rates Decline News and commentary from the endocrinology world Sep 10, 2016
Opioid Treatment Under Control at Large Urban Health System Majority of patients on lowest dosage per day Sep 09, 2016
MedPAC Looks at Ways to Adjust Misvalued Services Commission debates grouping CPT codes into families Sep 09, 2016
Hypomethylating Agents Useful in Low-Risk MDS Objective responses in a majority of patients Sep 08, 2016
Concussions at Altitude: No Longer Worth Investigating? Researchers suggest issue is resolved; others say not so fast Sep 07, 2016
